Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Proinflammatory Cytokines could help improve the diagnosis and treatment of prostate cancer

03.12.2008
Researchers from the University of Alcalá (UAH) have concluded that there could be a link between the high expression of proinflammatory Cytokines and high levels of prostate specific antigen (PSA) with the progression of prostate cancer.

Prostate cancer is one of the most common tumours affecting the male population, and a digital rectal examination is the main method for an early detection.

Several years ago, prostate specific antigen (PSA) levels where introduced as a diagnostic test and follow-up of the disease, but there are alternative situations such as manipulation of the prostate gland in a biopsy or a rectal exam, and other benign diseases like hyperplasia, that cause a temporary elevation of PSA levels leading to false positives.

The opposite is also true, since normal levels of PSA have been measured in patients suffering the tumoural pathology. Therefore the prostate specific antigen is not an indication of the degree of development of the disease.

The researchers of the department of genetics and cell biology at the University of Alcalá decided to look for new prognostic markers that together with the PSA would increase the diagnostic specificity of the disease. The molecules selected for the study where Proinflammatory Cytokines that already play an important role in the development of the cancer. Their work consisted in relating the expression of different Proinflammatory Cytokines, Interleuquines 1 & 6 and the necrosis factor-alpha (TFN-a), with the levels of prostate specific antigen (PSA) in blood serum, both for normal patients (without tumoural pathology), as well as for pathologic conditions (hyperplasia and cancer), while also relating them to their role in tumour progression as stated by Mar Royuela.

To achieve this, they studied prostate samples of healthy patients with benign hyperplasia and with prostate cancer in collaboration with the researchers from the Université du 7 Novembre à Carthage of Tunisia. The results of the study, published in the journal Cancer detection and prevention, indicate that there could be a link between high expression of Proinflammatory Cytokines IL-1, TNF- a and IL-6 and high seric levels of PSA with the progression of the cancer. It is possible that a better understanding of the biological mechanism of such an association could lead to a therapeutic target in patients suffering from a prostate pathology, as the professor of Alcalá University explains.

The research group for solid tumour cellular biology and tissue regeneration at the UAH has dedicated over 10 years to the study of histology and cellular biology of the healthy and anomalous human prostate; work that was complemented by the study of breast cancer. Their line of thinking focuses on the intermediaries in the different transduction paths initiated by the TNF-alpha/ IL-1 that activate different transcription factors involved in cellular proliferation. “Cancer is a complex process that involves many factors. Only by knowing most of them we will be able to find an effective therapy”, Professor Royuela states. “In order to achieve this objective the investigation must continue. In our case, we propose to study one of bifurcations in the transcription routes which lead to the activation of NF-kB. In the future, we will complement our research with the study of the link between these paths and the family of proteins that inhibits apoptosis (cell death) and which acts mainly on caspases”, concludes the researcher of Alcalá University.

Oficina Información Científica | alfa
Further information:
http://www.uah.es

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Optical Nanoscope Allows Imaging of Quantum Dots

Physicists have developed a technique based on optical microscopy that can be used to create images of atoms on the nanoscale. In particular, the new method allows the imaging of quantum dots in a semiconductor chip. Together with colleagues from the University of Bochum, scientists from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute reported the findings in the journal Nature Photonics.

Microscopes allow us to see structures that are otherwise invisible to the human eye. However, conventional optical microscopes cannot be used to image...

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Rutgers scientists discover 'Legos of life'

23.01.2018 | Life Sciences

Seabed mining could destroy ecosystems

23.01.2018 | Earth Sciences

Transportable laser

23.01.2018 | Physics and Astronomy

VideoLinks Science & Research
Overview of more VideoLinks >>>